A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?
A higher dose of an emergency-contraception drug may open a back door for Americans seeking abortions in restrictive states.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. STAT is ...
The anti-abortion movement has launched a pressure campaign urging President Donald Trump’s administration to take steps ...
Judge Matthew Kacsmaryk, a Trump appointee, allowed three states to go forward with a lawsuit that seeks to change how ...
Trump-appointed Judge Matthew Kacsmaryk ruled Thursday that Idaho, Kansas, and Missouri can pursue legal action to prohibit ...
The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public ...
The goal of this study was to determine if ulipristal acetate and misoprostol could provide a safe and effective alternative ...